Order custom Harvard Business Case Study Analysis & Solution. Starting just $19
Fern Fort University
XTL Biopharmaceuticals Ltd. SWOT Analysis / Matrix
Business Essays, Term Papers & Research Papers
SWOT analysis is a vital strategic planning tool that can be used by XTL Biopharmaceuticals Ltd. managers to do a situational analysis of the firm . It is a handy technique to evalauate the present Strengths (S), Weakness (W), Opportunities (O) & Threats (T) XTL Biopharmaceuticals Ltd. is facing in its current business environment.
The XTL Biopharmaceuticals Ltd. is one of the leading firms in its industry. XTL Biopharmaceuticals Ltd. maintains its prominent position in market by carefully analyzing and reviewing the SWOT analysis. SWOT analysis a highly interactive process and requires effective coordination among various departments within the company such as – marketing, finance, operations, management information systems and strategic planning.
Order Now - XTL Biopharmaceuticals Ltd. SWOT Analysis
Check out- XTL Biopharmaceuticals Ltd. PESTEL / PEST & Environment Analysis
Article continues after advertisement
The SWOT Analysis framework facilitates an organization to identify the internal strategic factors such as -strengths and weaknesses, & external strategic factors such as - opportunities and threats. It leads to a 2X2 matrix – also known as SWOT Matrix.
The Strengths-Weaknesses-Opportunities-Threats (SWOT) Analysis / Matrix enables the managers of the XTL Biopharmaceuticals Ltd. to develop four types of strategies:
- SO (strengths-opportunities) Strategies
- WO (weaknesses-opportunities) Strategies
- ST (strengths-threats) Strategies
- WT (weaknesses-threats) Strategies
SWOT Matrix Strategies Objective
The main purpose of SWOT matrix is to identify the strategies that a company can use to exploit external opportunities, counter threats, and build on & protect XTL Biopharmaceuticals Ltd. strengths, and eradicate its weaknesses.
Step by Step Guide to XTL Biopharmaceuticals Ltd. SWOT Analysis
Strengths of XTL Biopharmaceuticals Ltd. – Internal Strategic Factors
As one of the leading organizations in its industry, XTL Biopharmaceuticals Ltd. has numerous strengths that help it to thrive in the market place. These strengths not only help it to protect the market share in existing markets but also help in penetrating new markets. Based on Fern Fort University extensive research – some of the strengths of XTL Biopharmaceuticals Ltd. are –
Read - XTL Biopharmaceuticals Ltd. Porter 5 Forces Analysis & Industry Analysis
Article continues after advertisement
- Strong Free Cash Flow – XTL Biopharmaceuticals Ltd. has strong free cash flows that provide resources in the hand of the company to expand into new projects.
- Automation of activities brought consistency of quality to XTL Biopharmaceuticals Ltd. products and has enabled the company to scale up and scale down based on the demand conditions in the market.
- Superb Performance in New Markets – XTL Biopharmaceuticals Ltd. has built expertise at entering new markets and making success of them. The expansion has helped the organization to build new revenue stream and diversify the economic cycle risk in the markets it operates in.
- Successful track record of developing new products – product innovation.
- High level of customer satisfaction – the company with its dedicated customer relationship management department has able to achieve a high level of customer satisfaction among present customers and good brand equity among the potential customers.
- Highly successful at Go To Market strategies for its products.
- Strong dealer community – It has built a culture among distributor & dealers where the dealers not only promote company’s products but also invest in training the sales team to explain to the customer how he/she can extract the maximum benefits out of the products.
- Strong Brand Portfolio – Over the years XTL Biopharmaceuticals Ltd. has invested in building a strong brand portfolio. The SWOT analysis of XTL Biopharmaceuticals Ltd. just underlines this fact. This brand portfolio can be extremely useful if the organization wants to expand into new product categories.
Weakness of XTL Biopharmaceuticals Ltd. – Internal Strategic Factors
Weakness are the areas where XTL Biopharmaceuticals Ltd. can improve upon. Strategy is about making choices and weakness are the areas where a company can improve using SWOT analysis and build on its competitive advantage and strategic positioning.
Article continues after advertisement
- Days inventory is high compare to the competitors – making the company raise more capital to invest in the channel. This can impact the long term growth of XTL Biopharmaceuticals Ltd.
- There are gaps in the product range sold by the company. This lack of choice can give a new competitor a foothold in the market.
- The company has not being able to tackle the challenges present by the new entrants in the segment and has lost small market share in the niche categories. XTL Biopharmaceuticals Ltd. has to build internal feedback mechanism directly from sales team on ground to counter these challenges.
- Financial planning is not done properly and efficiently. The current asset ratio and liquid asset ratios suggest that the company can use the cash more efficiently than what it is doing at present.
- High attrition rate in work force – compare to other organizations in the industry XTL Biopharmaceuticals Ltd. has a higher attrition rate and have to spend a lot more compare to its competitors on training and development of its employees.
- Limited success outside core business – Even though XTL Biopharmaceuticals Ltd. is one of the leading organizations in its industry it has faced challenges in moving to other product segments with its present culture.
- The profitability ratio and Net Contribution % of XTL Biopharmaceuticals Ltd. are below the industry average.
Opportunities for XTL Biopharmaceuticals Ltd. – External Strategic Factors
Article continues after advertisement
- Government green drive also opens an opportunity for procurement of XTL Biopharmaceuticals Ltd. products by the state as well as federal government contractors.
- The new technology provides an opportunity to XTL Biopharmaceuticals Ltd. to practices differentiated pricing strategy in the new market. It will enable the firm to maintain its loyal customers with great service and lure new customers through other value oriented propositions.
- The market development will lead to dilution of competitor’s advantage and enable XTL Biopharmaceuticals Ltd. to increase its competitiveness compare to the other competitors.
- Economic uptick and increase in customer spending, after years of recession and slow growth rate in the industry, is an opportunity for XTL Biopharmaceuticals Ltd. to capture new customers and increase its market share.
- Decreasing cost of transportation because of lower shipping prices can also bring down the cost of XTL Biopharmaceuticals Ltd.’s products thus providing an opportunity to the company - either to boost its profitability or pass on the benefits to the customers to gain market share.
- New trends in the consumer behavior can open up new market for the XTL Biopharmaceuticals Ltd. . It provides a great opportunity for the organization to build new revenue streams and diversify into new product categories too.
- New environmental policies – The new opportunities will create a level playing field for all the players in the industry. It represent a great opportunity for XTL Biopharmaceuticals Ltd. to drive home its advantage in new technology and gain market share in the new product category.
- New customers from online channel – Over the past few years the company has invested vast sum of money into the online platform. This investment has opened new sales channel for XTL Biopharmaceuticals Ltd.. In the next few years the company can leverage this opportunity by knowing its customer better and serving their needs using big data analytics.
Threats XTL Biopharmaceuticals Ltd. Facing - External Strategic Factors
- Imitation of the counterfeit and low quality product is also a threat to XTL Biopharmaceuticals Ltd.’s product especially in the emerging markets and low income markets.
- No regular supply of innovative products – Over the years the company has developed numerous products but those are often response to the development by other players. Secondly the supply of new products is not regular thus leading to high and low swings in the sales number over period of time.
- Shortage of skilled workforce in certain global market represents a threat to steady growth of profits for XTL Biopharmaceuticals Ltd. in those markets.
- As the company is operating in numerous countries it is exposed to currency fluctuations especially given the volatile political climate in number of markets across the world.
- Liability laws in different countries are different and XTL Biopharmaceuticals Ltd. may be exposed to various liability claims given change in policies in those markets.
- Rising raw material can pose a threat to the XTL Biopharmaceuticals Ltd. profitability.
- Growing strengths of local distributors also presents a threat in some markets as the competition is paying higher margins to the local distributors.
- Rising pay level especially movements such as $15 an hour and increasing prices in the China can lead to serious pressure on profitability of XTL Biopharmaceuticals Ltd.
Limitations of SWOT Analysis for XTL Biopharmaceuticals Ltd.
Although the SWOT analysis is widely used as a strategic planning tool, the analysis does have its share of limitations.
- Certain capabilities or factors of an organization can be both a strength and weakness at the same time. This is one of the major limitations of SWOT analysis . For example changing environmental regulations can be both a threat to company it can also be an opportunity in a sense that it will enable the company to be on a level playing field or at advantage to competitors if it able to develop the products faster than the competitors.
- SWOT does not show how to achieve a competitive advantage, so it must not be an end in itself.
- The matrix is only a starting point for a discussion on how proposed strategies could be implemented. It provided an evaluation window but not an implementation plan based on strategic competitiveness of XTL Biopharmaceuticals Ltd.
- SWOT is a static assessment - analysis of status quo with few prospective changes. As circumstances, capabilities, threats, and strategies change, the dynamics of a competitive environment may not be revealed in a single matrix.
- SWOT analysis may lead the firm to overemphasize a single internal or external factor in formulating strategies. There are interrelationships among the key internal and external factors that SWOT does not reveal that may be important in devising strategies.
Article continues after advertisement
Weighted SWOT Analysis of XTL Biopharmaceuticals Ltd.
In light of the above mentioned limitations of the SWOT analysis / matrix, corporate managers decided to provide weightage to each internal strength and weakness of the firm. Organizations also assess the likelihood of events taking place in the coming future and how strong their impact could be on company's performance.
This method is called Weighted SWOT analysis. It is better than doing simplistic SWOT analysis because with Weighted SWOT Analysis XTL Biopharmaceuticals Ltd. managers can focus on the most critical factors and discount the non-important one. It also solves the long list problem where organizations ends up making a long list but none of the factors deemed too critical.
Limitation of Weighted SWOT analysis of XTL Biopharmaceuticals Ltd.
This approach also suffers from one major drawback - it focus on individual importance of factor rather than how they are collectively important and impact the business holistically.
Buy Custom Essay and Term Paper on SWOT Analysis / Matrix , Weighted SWOT Analysis of XTL Biopharmaceuticals Ltd.
Example of Weighted SWOT Analysis
You can email us to get an example document of Weighted SWOT analysis.
SWOT Worksheet & Template
If you like to do your own SWOT analysis or want to make your own Weighted SWOT SWOT matrix then feel free to download Fern Fort University SWOT Analysis Template.
References / Citations & Bibliography
- M. E. Porter, Competitive Strategy(New York: Free Press, 1980)
- A. D. Chandler, Strategy and Structure (Cambridge, Mass.: MIT Press, 1962)
- O. E. Williamson, Markets and Hierarchies(New York: Free Press, 1975);
- L. Wrigley, Divisional Autonomy and Diversification (PhD, Harvard Business School, 1970)
- R. E. White, Generic Business Strategies, Organizational Context and Performance: An Empirical Investigation, Strategic Management Journal7 (1986)
Order Now
Previous 5 SWOT Analysis
- DENTSPLY SIRONA Inc. SWOT Analysis
- Intrexon Corporation SWOT Analysis
- XOMA Corporation SWOT Analysis
- Xencor, Inc. SWOT Analysis
- Acceleron Pharma Inc. SWOT Analysis
Next 5 SWOT Analysis
- Xtant Medical Holdings, Inc. SWOT Analysis
- 22nd Century Group, Inc. SWOT Analysis
- Zimmer Biomet Holdings, Inc. SWOT Analysis
- Zafgen, Inc. SWOT Analysis
- Zogenix, Inc. SWOT Analysis
HBR Case Studies Solutions
- The World Food Programme during the Global Food Crisis (B) case study solution
- Netflix: Going Public case study solution
- NaanDanJain: Every Drop of Water Counts case study solution
- BRADFORD DEVELOPMENT - Confidential Information for the Mayor's Representative case study solution
- China: To Float or Not to Float? (E): ABB Investment in China case study solution